Skip to main content
Equibles

D. E. Shaw & Co., Inc.

Position in CRMD — CorMedix Inc.

CIK 1009207 New York, NY
Back to CRMD Full portfolio

Position in CRMD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,348,684
+$111,555 QoQ
Shares Held
171,807
+61.5% QoQ
Ownership
0.220%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 194 holders
Holding Since
Dec 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRMD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,139,216,221 across 217 Biotechnology names. CRMD ranks #146 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 5,877,959 $626,707,987
2 ALNY
Alnylam Pharmaceuticals, Inc.
 1,104,109 $332,369,932
3 EXEL
Exelixis, Inc.
 5,551,747 $302,070,554
4 BBIO
BridgeBio Pharma, Inc.
 3,633,007 $270,586,360
5 TGTX
Tg Therapeutics, Inc.
 3,400,808 $186,840,390
6 HALO
Halozyme Therapeutics, Inc.
 2,006,479 $157,047,110
7 AXSM
Axsome Therapeutics, Inc.
 604,753 $148,025,391
8 PTCT
Ptc Therapeutics, Inc.
 1,548,919 $126,345,322

All Filings in CRMD

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,348,684 171,807
2025-12-31 $1,237,129 106,374
2025-06-30 $2,707,985 219,804
2025-03-31 $1,420,508 230,602
2024-12-31 $3,615,953 446,414
2024-09-30 $2,593,590 320,989
2024-06-30 $563,955 130,244
2024-03-31 $548,533 129,371
2023-12-31 $538,721 143,277
2023-09-30 $689,121 186,249
2023-06-30 $203,676 51,304
2022-12-31 $611,207 144,836
2022-09-30 $145,317 51,349
2022-06-30 $55,556 13,820
2022-03-31 $62,992 11,495
2020-12-31 $318,160 42,821